Kathleen M Schmainda
Overview
Explore the profile of Kathleen M Schmainda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
2020
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shiroishi M, Erickson B, Hu L, Barboriak D, Becerra L, Bell L, et al.
Radiology
. 2024 Dec;
313(3):e232555.
PMID: 39656118
The dynamic susceptibility contrast (DSC) MRI measures of relative cerebral blood volume (rCBV) play a central role in monitoring therapeutic response and disease progression in patients with gliomas. Previous investigations...
2.
Loizzo S, Prah M, Kong M, Phung D, Urcuyo J, Ye J, et al.
AJNR Am J Neuroradiol
. 2024 Oct;
46(3):529-535.
PMID: 39389776
Background And Purpose: A national consensus recommendation for the collection of DSC-MRI perfusion data, used to create maps of relative CBV (rCBV), has been recently established for primary and metastatic...
3.
Gagnon L, Gupta D, Mastorakos G, White N, Goodwill V, McDonald C, et al.
Radiol Artif Intell
. 2024 Aug;
6(5):e230489.
PMID: 39166970
Purpose To develop and validate a deep learning (DL) method to detect and segment enhancing and nonenhancing cellular tumor on pre- and posttreatment MRI scans in patients with glioblastoma and...
4.
Laing B, Prah M, Best B, Krucoff M, Mueller W, Schmainda K
Neurosurg Pract
. 2024 Jun;
5(1).
PMID: 38919518
Background And Objectives: Gross-total resection (GTR) and low residual tumor volume (RTV) have been associated with increased survival in glioblastoma. Largely due to the subjectivity involved, the determination of GTR...
5.
Anil A, Stokes A, Karis J, Bell L, Eschbacher J, Jennings K, et al.
AJNR Am J Neuroradiol
. 2024 May;
45(10):1545-1551.
PMID: 38782593
Background And Purpose: DSC-MR imaging can be used to generate fractional tumor burden (FTB) maps via application of relative CBV thresholds to spatially differentiate glioblastoma recurrence from posttreatment radiation effects...
6.
Prah M, Schmainda K
Front Radiol
. 2024 Mar;
4:1307586.
PMID: 38445104
Relative cerebral blood volume (rCBV) derived from dynamic susceptibility contrast (DSC) perfusion MR imaging (pMRI) has been shown to be a robust marker of neuroradiological tumor burden. Recent consensus recommendations...
7.
Al-Gizawiy M, Wujek R, Alhajala H, Cobb J, Prah M, Doan N, et al.
Front Oncol
. 2024 Jan;
13:1278157.
PMID: 38288102
Background: Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. Emerging data indicate that trGBM iron metabolism is an attractive...
8.
Botros N, Polinger-Hyman D, Beck R, Kleefisch C, Mrachek E, Connelly J, et al.
J Neurosurg Case Lessons
. 2023 Dec;
6(25).
PMID: 38109728
Background: Neurocysticercosis (NCC) is a parasitic infection of the brain caused by ingesting water or food contaminated with tapeworm eggs. When it presents as a solitary mass, differentiation from a...
9.
Shiroishi M, Weinert D, Cen S, Varghese B, Dondlinger T, Prah M, et al.
Front Oncol
. 2023 Oct;
13:1156843.
PMID: 37799462
Introduction: 1.5 Tesla (1.5T) remain a significant field strength for brain imaging worldwide. Recent computer simulations and clinical studies at 3T MRI have suggested that dynamic susceptibility contrast (DSC) MRI...
10.
Hu L, DAngelo F, Weiskittel T, Caruso F, Fortin Ensign S, Blomquist M, et al.
Nat Commun
. 2023 Sep;
14(1):6066.
PMID: 37770427
Sampling restrictions have hindered the comprehensive study of invasive non-enhancing (NE) high-grade glioma (HGG) cell populations driving tumor progression. Here, we present an integrated multi-omic analysis of spatially matched molecular...